Sana Biotechnology
Biotechnology, 188 E Blaine St Suit 400, Seattle, Washington, 98102, United States, 201-500 Employees
Phone Number: 20********
Who is SANA BIOTECHNOLOGY
Sana Biotechnology is focused on utilizing engineered cells as medicines for patients. The ability to modify genes and use cells as medicines will be one of the most important advances in...
Read More
-
Headquarters: 188 E Blaine St Suit 400, Seattle, Washington, 98102, United States
-
Date Founded: 2018
-
Employees: 201-500
-
Revenue: $100 Million to $250 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 2836
|
NAICS Code: 325414 |
Show More
Does something look wrong? Fix it. | View contact records from SANA BIOTECHNOLOGY
Sana Biotechnology Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Sana Biotechnology
Answer: Sana Biotechnology's headquarters are located at 188 E Blaine St Suit 400, Seattle, Washington, 98102, United States
Answer: Sana Biotechnology's phone number is 20********
Answer: Sana Biotechnology's official website is https://sana.com
Answer: Sana Biotechnology's revenue is $100 Million to $250 Million
Answer: Sana Biotechnology's SIC: 2836
Answer: Sana Biotechnology's NAICS: 325414
Answer: Sana Biotechnology has 201-500 employees
Answer: Sana Biotechnology is in Biotechnology
Answer: Sana Biotechnology contact info: Phone number: 20******** Website: https://sana.com
Answer: Sana Biotechnology is focused on utilizing engineered cells as medicines for patients. The ability to modify genes and use cells as medicines will be one of the most important advances in healthcare over the next several decades. Sana is building differentiated capabilities across the spectrum of cell and gene therapy. Three aspirations drive Sana as we look to discover treatments for patients with poor outcomes or currently untreatable diseases. The first is the ability to repair and control the genes in any cell in the body. We are advancing novel delivery technologies with the goal of being able to deliver any payload to any cell in a specific, predictable, and repeatable manner, paving the way for next-generation in vivo gene therapy. Next is the ability to differentiate pluripotent stem cells ex vivo into immune-cloaked functional cells with the aspiration of being able to replace any missing or damaged cells in the body. Last is a belief we can enable broader access to our therapies through focusing on scalable manufacturing solutions, the cost of manufacturing, and aligning with key stakeholders. Sana launched in early 2019 and has over 350 employees in Seattle, Cambridge, and South San Francisco. Sana was founded with the long view bringing together great people and the best technologies to deliver on the challenging promise of using engineered cells to meaningfully change the outcome of many human diseases.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month